RSSCategory: Malaria

PATH names Steve Davis president and CEO

PATH names Steve Davis president and CEO

Davis will oversee PATH’s annual budget of $305 million, a staff of nearly 1,200, and a portfolio of projects based in PATH offices in 22 countries. He succeeds Dr. Christopher J. Elias, who left PATH to become president of the Global Development Program at the Bill & Melinda Gates Foundation.

Share
March 26, 2012 | By | Reply More
Promising malaria vaccine results released at Seattle conference

Promising malaria vaccine results released at Seattle conference

A malaria vaccine developed by the pharmaceutical company GSK and Seattle’s PATH has been shown to halve the risk of severe malaria in African children.

Share
October 18, 2011 | By | Reply More
Global health funding continues to grow, though more slowly – UW researchers report

Global health funding continues to grow, though more slowly – UW researchers report

Despite the world economic crisis, funding for global health from both public and private donors continues to rise, albeit more slowly, according to a report by the Institute for Health Metrics and Evaluation at the University of Washington in Seattle.

But aid is not necessarily going where the need is greatest, the report finds.

Share
November 30, 2010 | By | Reply More
Gates Foundation advances controversial drive to eradicate malaria–Seattle Times

Gates Foundation advances controversial drive to eradicate malaria–Seattle Times

Sandi Doughton reports about new developments in the Foundation’s initiative.

Share
September 10, 2010 | By | Reply More
Seattle “Smart” Global Health Policy Forum Online

Seattle “Smart” Global Health Policy Forum Online

Two-hour forum on reforming U.S. global health practices was held in Seattle Thursday will be available online.

Share
July 29, 2010 | By | Reply More
Is malaria eradication possible?

Is malaria eradication possible?

Seattle global health blogger Tom Paulson reports on PATH’s World Malaria Day conference.

Share
April 27, 2010 | By | Reply More